We are live on ! Find out more
TCIM

TIAA CREF Investment Management Portfolio holdings

AUM $141B
1-Year Est. Return 14.18%
This Fund
S&P 500
This Quarter Est. Return
+1.32%
1 Year Est. Return
+14.18%
3 Year Est. Return
+70.08%
5 Year Est. Return
+108.37%
10 Year Est. Return
AUM
$141B
AUM Growth
-$3.04B
Cap. Flow
-$3.19B
Cap. Flow %
-2.27%
Top 10 Hldgs %
14.96%
Holding
3,181
New
67
Increased
776
Reduced
2,147
Closed
56

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$184M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$149M
3
BABA icon
Alibaba
BABA
+$112M
4
AGN
Allergan plc
AGN
+$88.9M
5
TWX
Time Warner Inc
TWX
+$87.1M

Sector Composition

Rank Sector Weight
1 Technology 15.21%
2 Healthcare 14.14%
3 Financials 13.82%
4 Industrials 10.91%
5 Consumer Discretionary 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GUID
3001
DELISTED
Guidance Software, Inc.
GUID
$448K ﹤0.01%
66,587
AMRS
3002
DELISTED
Amyris Inc.
AMRS
$444K ﹤0.01%
7,817
-866
-10% -$51.2K
PAYC icon
3003
Paycom
PAYC
$9.69B
$443K ﹤0.01%
26,723
ISH
3004
DELISTED
INTL SHIPHOLDING CORP
ISH
$441K ﹤0.01%
24,650
-1,066
-4% -$22.6K
ADNC
3005
DELISTED
AUDIENCE INC COM STK (DE)
ADNC
$438K ﹤0.01%
59,176
-1,949
-3% -$17.9K
ATEN icon
3006
A10 Networks
ATEN
$1.95B
$433K ﹤0.01%
47,524
COB
3007
DELISTED
CommunityOne Bancorp
COB
$430K ﹤0.01%
48,789
TNDM icon
3008
Tandem Diabetes Care
TNDM
$1.56B
$429K ﹤0.01%
3,196
HMTV
3009
DELISTED
Hemisphere Media Group, Inc.
HMTV
$427K ﹤0.01%
40,087
ALDR
3010
DELISTED
Alder Biopharmaceuticals
ALDR
$426K ﹤0.01%
33,584
+2,780
+9% +$42K
VRNS icon
3011
Varonis Systems
VRNS
$5B
$424K ﹤0.01%
60,276
QADA
3012
DELISTED
QAD Inc.
QADA
$421K ﹤0.01%
22,636
-7,366
-25% -$148K
RYZ
3013
Ryerson Holding Corp
RYZ
$1.46B
$413K ﹤0.01%
+32,285
New +$369K
BITA
3014
DELISTED
Bitauto Holdings Limited
BITA
$413K ﹤0.01%
+5,300
New +$371K
YUME
3015
DELISTED
YuMe, Inc.
YUME
$412K ﹤0.01%
82,346
+700
+0.9% +$3.92K
INGN icon
3016
Inogen
INGN
$164M
$404K ﹤0.01%
19,624
NSTG
3017
DELISTED
NanoString Technologies, Inc.
NSTG
$404K ﹤0.01%
36,906
-1,725
-4% -$21.3K
DRNA
3018
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$401K ﹤0.01%
31,494
+957
+3% +$14.4K
MFLX
3019
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
$401K ﹤0.01%
42,893
-2,507
-6% -$25.6K
PRKR
3020
DELISTED
Parkervision Inc
PRKR
$398K ﹤0.01%
34,889
-1,690
-5% -$21.4K
SCMP
3021
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$394K ﹤0.01%
60,612
-3,247
-5% -$21.6K
EVDY
3022
DELISTED
Everyday Health, Inc.
EVDY
$393K ﹤0.01%
28,111
SAGE
3023
DELISTED
Sage Therapeutics
SAGE
$387K ﹤0.01%
+12,297
New +$356K
UCP
3024
DELISTED
UCP, Inc.
UCP
$387K ﹤0.01%
32,412
-1,600
-5% -$20.3K
SALM
3025
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$384K ﹤0.01%
50,496

Similar funds

TIAA CREF Investment Management's Q3 2014 Portfolio in Review

As of Q3 2014, TIAA CREF Investment Management held 3,181 positions worth $141B, down 2.1% from $144B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 3.9%. TIAA CREF Investment Management opened 67 new positions and exited 56, leaving the 3,181-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • TIAA CREF Investment Management's largest Q3 2014 buy was Alibaba: 1,249,500 shares worth $111M.
  • TIAA CREF Investment Management added most to Tesla in Q3 2014, an estimated $184M increase.
  • TIAA CREF Investment Management's biggest Q3 2014 reduction was LyondellBasell Industries, cutting an estimated $282M.
  • TIAA CREF Investment Management fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $105M.
  • TIAA CREF Investment Management's ten largest holdings make up 15% of its $141B portfolio in Q3 2014.
  • TIAA CREF Investment Management opened 67 new positions and closed 56 in Q3 2014.
  • TIAA CREF Investment Management's portfolio value fell 2.1% quarter-over-quarter to $141B.

Based on TIAA CREF Investment Management's 13F filing for Q3 2014, filed 13 Nov 2014.